Efficacy of S-1 in Advanced Non-small Cell Lung Cancer Patients Treated 
with More Than Two Lines of Chemotherapy

Efficacy of S-1 in Advanced Non-small Cell Lung Cancer Patients Treated 
with More Than Two Lines of Chemotherapy

Background and objective There is no standard treatment for advanced non-small cell lung cancer (NSCLC) after the failure of two lines of chemotherapy, S-1 as the third generation of fluorouracil derivate with well safety and low toxicity, presented some efficacy in lung cancer treatment. The aim of...

Full description

Bibliographic Details
Main Authors: Yi YIN, Biao WU, Zhangzhou HUANG, Wu ZHUANG, Zhenwu XU, Cheng HUANG, Yunjian HUANG, Jing ZHANG
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2018-06-01
Series:Chinese Journal of Lung Cancer
Subjects:
S-1
Lung neoplasms
Chemotherapy
Drug resistance
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2018.06.03

Internet

http://dx.doi.org/10.3779/j.issn.1009-3419.2018.06.03

Similar Items